Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 1 of the last 3 fiscal years.
-
Two loss years in a row NBB
Negative result in 2022 and 2023.
-
Legal situation KBO
Opening faillissement according to the CBE.
Financials
Financial year 2023
Quantoom Biosciences from Nivelles, company number BE0744643858, closed financial year 2023 with a result of € -14.2 million after tax. For that financial year Quantoom Biosciences recorded revenue of € 8.3 million and equity of € -1.2 million. Compared with financial year 2022, the result moved from € -11.6 million to € -14.2 million. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 4, 2024.
€ -1.2 million
▼ € 10.9 million vs 2022
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -14.2 million
▼ 23 % more loss than in 2022
Profit after tax over the fiscal year.
€ 11.1 million
▲ 55% vs 2022
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -8.4 million.
People and assets in 2023
69.1
▲ 19.7 vs 2022
Average over the fiscal year, from the social balance sheet.
€ 7 million
▲ 50% vs 2022
€ 100,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 874,286
▼ 28% vs 2022
Of which on lease € 817,306.
Debts at end 2023
€ 421,007
▼ 54% vs 2022
€ 348,065 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.
€ 9.9 million
▲ 88% vs 2022
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 248 days on average.
€ 1.4 million
▲ 58% vs 2022
Taxes, VAT and social contributions still to pay.
| 2021 | 2022 | 2023 | Change 2022 → 2023 | |
|---|---|---|---|---|
| Revenue | - | - | € 8,273,283 | |
| Profit after taxes | € -7,688,909 | € -11,577,461 | € -14,230,664 | ▼ € 2.7 million |
| Equity | € 8,571,441 | € 9,694,354 | € -1,176,622 | ▼ € 10.9 million |
| Total debts | € 21,999,031 | € 24,448,962 | € 58,388,686 | ▲ 139% |
| Cash | € 5,373,612 | € 7,132,768 | € 11,055,647 | ▲ 55% |
| Retained profit | € -7,178,264 | € -7,661,954 | € -8,371,522 | ▼ € 709,568 |
| Bank debt | € 1,420,174 | € 906,485 | € 421,007 | ▼ 54% |
| Balance sheet total | € 30,629,776 | € 34,156,354 | € 57,267,064 | ▲ 68% |
| Employees (FTE) | 40.1 | 49.4 | 69.1 | ▲ 19.7 |
Key figures of Quantoom Biosciences, fiscal years 2021 to 2023, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2024 has not been filed yet; it was expected before 31 July 2025.
What happened to Quantoom Biosciences?
What happened at Quantoom Biosciences in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
Quantoom Biosciences is active according to the CBE. Legal situation: Opening faillissement.
- ANTROBUS SRL stepped down as director. NBB
- Hugues BULTOT stepped down as director. NBB
- José CASTILLO stepped down as director. NBB
- New annual accounts for financial year 2023: loss of € 14.2 million. Source: NBB ↗
- Aziz KABEER stepped down as director. NBB
- Pierre MORGON stepped down as director. NBB
- Jean-Paul PRIEELS stepped down as director. NBB
- ANTROBUS SRL became a director. NBB
In short
From € 7.7 million loss in 2021 to € 14.2 million loss in 2023.
Management
The stake of UNIVERCELLS comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Quantoom BiosciencesThe shares are held by UNIVERCELLS (100%).
Directors
According to the 2023 annual accounts
Aziz KABEER
Director
since 2020 · until 2023
Hugues BULTOT
Director
Also active at: H ET B MANAGEMENT, UNIVERCELLS, EXOTHERA, UNIZIMA, Quantoom Bioservices, RLM Consulting
since 2020 · until 2026
since 2020 · until 2026
Pierre MORGON
Director
since 2020 · until 2023
since 2021 · until 2023
since 2021 · until 2027
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
rue de la Maitrise 11
1400 Nivelles
Herrmann-Debrouxlaan 54
1160 Oudergem
Active since 2 March 2020
Zoning de Jumet,4ème rue 52
6040 Charleroi
Active since 2 March 2020
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
VERIXI, BE
Domain
Domain
quantoom.co
Registered
2025-09-02
Registrar
Global Domain Group LLC
Expires
2026-09-02
Website info
Features
Security
Details
- Company number
- 0744.643.858
- VAT number
- BE 0744.643.858
- Registered office
- rue de la Maitrise 11, 1400 Nivelles
- Names & denominations
- Quantoom Biosciences
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Opening faillissement
- Start date
- 2 March 2020
- Peppol
- Not registered
- Contact
- quantoom.co
- Activities · NACE
Vervaardiging van geneesmiddelen
Speur- en ontwikkelingswerk op biotechnologisch gebied